Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

ClinicalTrials.gov ID: NCT00959049

Public ClinicalTrials.gov record NCT00959049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Observer-blind, Multi-center, Noninferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Trivalent Inactivated Split-Virion Influenza Vaccine in a Pediatric Population Aged Greater Than or Equal to 6 Months to Less Than 18 Years.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the immunogenicity and safety profile of CSL Limited's Influenza Virus Vaccine compared to a US licensed comparator Influenza Virus Vaccine in a pediatric population aged greater than or equal to 6 months to less than 18 years.

Study identification

NCT ID
NCT00959049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Seqirus
Industry
Enrollment
1,474 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
May 2010 (Actual)
Last update posted
May 16, 2017

2009 – 2010

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Not listed Chandler Arizona 85224 —
Not listed Harrisburg Arkansas 72432 —
Not listed Jonesboro Arkansas 72401 —
Not listed Little Rock Arkansas 72205 —
Not listed Mountain Home Arkansas 72653 —
Not listed Melbourne Florida 32935 —
Not listed Bardstown Kentucky 40004 —
Not listed Omaha Nebraska 68134 —
Not listed Binghamton New York 13901 —
Not listed Elmira New York 14901 —
Cincinnati Children's Hospital Medical Center- Division of Infectious Disease Cincinnati Ohio 45229 —
Not listed Warr Acres Oklahoma 73132 —
UPMC / Community Medicine Inc Greenville Pennsylvania 16125 —
Pediatric Associates of Latrobe Latrobe Pennsylvania 15650 —
Pediatric Alliance Greentree Division Pittsburgh Pennsylvania 15220 —
South Hills Pediatrics Pittsburgh Pennsylvania 15227 —
Not listed Pittsburgh Pennsylvania 15241 —
Not listed Salt Lake City Utah 84109 —
Not listed Salt Lake City Utah 84121 —
Not listed Salt Lake City Utah 84124 —
Not listed South Jordan Utah 84095 —
Not listed Burke Virginia 22015 —
Not listed Vienna Virginia 22180 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00959049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00959049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →